scholarly journals Use of bioresonance therapy in complex treatment of patients with diabetes mellitus type 2

2017 ◽  
Vol 98 (3) ◽  
pp. 334-337
Author(s):  
V V Kir’yanova ◽  
N V Vorokhobina ◽  
Z Kh Makhramov
Keyword(s):  
Diabetes Mellitus ◽  
Placebo Group ◽  
Diabetes Mellitus Type 2 ◽  
Diabetes Mellitus Type ◽  
Control Group ◽  
Study Group ◽  
Complex Treatment ◽  
Patients With Diabetes ◽  
Bioresonance Therapy

Aim. To evaluate the effectiveness of bioresonance therapy use in complex treatment of patients with diabetes mellitus type 2. Methods. The treatment scheme including bioresonance therapy is offered for patients with diabetes mellitus type 2. All 413 patients were assigned to 3 comparable groups: the study group included 198 patients, control group - 72 patients, placebo group - 143 patients. Duration of diabetes in the study group was 5.47±0.37 years, in control group - 4.03±0.46 years, in placebo group - 4.97±0.39 years. All patients were treated according to the traditional scheme of treatment of type 2 diabetes. The study group in addition to pharmacotherapy received bioresonance therapy. Control group received only drug treatment and placebo group received drug therapy and bioresonance simulation procedures. All patients were checked for glycated hemoglobin, fasting plasma glucose, blood glucose 2 hours after a meal, urine glucose, and body mass index on admission and 3 months after treatment. Results. Results of glycated hemoglobin, fasting plasma glucose, blood glucose 2 hours after a meal, urine glucose, and body mass index revealed that initially studied parameters in all three groups were high. After the bioresonance therapy in complex treatment of patients with diabetes type 2 in the study group all studied parameters were statistically significantly lower compared to control and placebo groups. Conclusion. The obtained results indicate the effectiveness of bioresonance therapy use in complex treatment of patients with diabetes mellitus type 2.

scholarly journals VITAMIN D AND DIABETES MELLITUS TYPE 2

2017 ◽  
Author(s):  
N. V. Pasyechko ◽  
V. M. Kulchinska ◽  
L. V. Radetska ◽  
L. V. Naumova ◽  
I. V. Smachylo ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Vitamin D ◽  
Carbohydrate Metabolism ◽  
Diabetes Mellitus Type 2 ◽  
Glycated Haemoglobin ◽  
Diabetes Mellitus Type ◽  
Control Group ◽  
Metabolic Disturbances ◽  
Patients With Diabetes

Background. As it is established that diabetes mellitus causes metabolic disturbances of all types (first of all because of carbohydrate metabolism), affection of blood vessels, nerves, different organs and tissues. However, the influence of DM on the level of microelements is still not investigated enough. Despite the sufficient variety of medicaments, compensation of diabetes mellitus is achieved in less than 30% of patients. For this reason, the search of new ways of treatment which are aimed at the improvement of carbohydrate metabolism is an urgent issue.Objective. The research was aimed to reveal the deficiency of 25-hydroxyvitamin D3 [25(OH)D3] and its correlation with carbohydrate metabolism.Materials and methods. Thirty five patients with diabetes mellitus Type 2 aged 55-74 with illness duration 2-4 years were examined. The control group included 35 healthy people of the same age and sex. Levels of 25-hydroxyvitamin D3 [25(OH)D3] were tested by means of radioimmunoassay. The level of glycated haemoglobin was tested by means of liquid chromatography.Results. Correlation of the level of vitamin D with the degree of diabetes mellitus Type 2 compensation has been detected.Conclusions. A clear tendency to the improvement of diabetes mellitus Type 2 compensation after medication correction with vitamin D was evidenced. 

scholarly journals The effect of Ketogenic diet on vitamin D3 and testosterone hormone in patients with diabetes mellitus type 2

2020 ◽  
Vol 33 (4) ◽  
pp. 202-205
Author(s):  
Hayder Almsaid ◽  
Hydar Muhsin Khalfa
Keyword(s):  
Diabetes Mellitus ◽  
Ketogenic Diet ◽  
Vitamin D3 ◽  
Diabetes Mellitus Type 2 ◽  
The Body ◽  
Diabetes Mellitus Type ◽  
Control Group ◽  
Diabetic Patients ◽  
Patients With Diabetes

Abstract A keto diet is well-known for being a low carb diet in which the body produces ketones in the liver to be used as energy. When something high in carbs is eaten, the body will produce glucose and insulin. Glucose is the easiest molecule for the body to convert and use as energy, so it will be chosen over any other energy source. The aim of this study is to examine the effect of a ketogenic diet on type 2 diabetic patients and the effect it has on testosterone, vitamin D3, HDL, LDL levels, in comparison to non-ketogenic diet subjects. In the study, Type 2 diabetic patients undergoing a keto diet were selected and serum D3 levels and testosterone levels were examined and compared with control subjects. The result show a significant increase in testosterone hormone in patients with diabetes mellitus type 2 following a Ketogenic diet (mean± Std. Error 427.4±2.52) as compared with the control group (mean ± Std. Error 422.2±0.24) and as compared with patients with diabetes mellitus type 2 who are not following a Ketogenic diet (mean± Std. Error 151.4±1.41). The results show no significant level in LDL level in patients with diabetes mellitus type 2 following a Ketogenic diet (mean ± Std. Error 78.53±0.17), as compared to a control group (mean ± Std. Error 75.0.3±0.14) and no significant level in HDL level in patients with diabetes mellitus type 2 following a Ketogenic diet (mean± Std. Error 46.3±1.55), as compared with a control group (mean ± Std. Error 46.2±2.43), and with patients with diabetes mellitus type 2 who are not following a Ketogenic diet (mean ± Std. Error 45.1±1.55). The results show a significant increase in vitamin D3 level in patient with diabetes mellitus type 2 who are following a Ketogenic diet (mean ± Std. Error 53.5±0.32), as compared with a control group (mean± Std. Error 57±0.24), and with patients with diabetes mellitus type 2 who are not following a Ketogenic diet (mean ± Std. Error 25.1±1.55). Herein, normal vitamin D3 levels in patients corresponds to normal testosterone hormone levels. In conclusion, this study shows that in patients with diabetes mellitus type 2, following a ketogenic diet has a positive effect on the patients’ health.

scholarly journals Association between obesity and depression in patients with diabetes mellitus type 2; a study protocol

F1000Research ◽  
2015 ◽  
Vol 4 ◽  
pp. 7 ◽  
Author(s):  
Eduardo De la Cruz-Cano ◽  
Carlos Alfonso Tovilla-Zarate ◽  
Emilio Reyes-Ramos ◽  
Thelma Beatriz Gonzalez-Castro ◽  
Isela Juarez-Castro ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Diabetes Mellitus Type 2 ◽  
Cross Sectional Study ◽  
Diabetes Mellitus Type ◽  
Sectional Study ◽  
Cross Sectional ◽  
The World ◽  
Patients With Diabetes

Background: Diabetes mellitus and depression are highly prevalent conditions throughout the world and have significant impact on health outcomes. It has been estimated that diabetes mellitus type 2 affects about 246 million people in the world; nevertheless, incidence varies among countries. There is evidence that depression is associated with a poor metabolic control in patients with type 2 diabetes mellitus that present other health problems (such as hypertension and obesity). The aim of this study protocol is to determine if obesity increases the risk for depression in patient with diabetes type 2.Methods: The analysis will be reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).The studies suitable for inclusion will be assessed by the Newcastle-Ottawa Scale (NOS) to determine their methodological quality. To identify the studies of interest, we will search on PubMed and EBSCO databases. We will use the following keyword combinations: "Diabetes Mellitus type 2 AND obesity AND depression", "depression AND Diabetes Mellitus type 2", "Diabetes Mellitus type 2 AND body mass index cross sectional study", "depression AND obesity cross-sectional study". Causes for exclusion will be publications that studied patients diagnosed with diabetes mellitus type 1; articles that focused on the treatment and complications of diabetes mellitus type 2; publications that have studied other clinical or psychiatric conditions (for instance, seizure disorder or history of schizophrenia, bipolar disorder, psychotic symptoms or dementia).Conclusion: The results of this study will form the basis for a better understanding of the association between obesity and depression in patients with diabetes mellitus type 2, and will allow development of prediction tools and better interventions. It is evident that several modifiable and non-modifiable risk factors play an important role in the pathogenesis of diabetes among population. Currently, evidence for the deleterious effects of diabetes mellitus type 2 are based on cross-sectional or other observational designs. Therefore, this study will have important implications for future research and public health guidance.

Sign in / Sign up

Export Citation Format

Share Document